The effect of acetylcholine on pain-related electric activities in the hippocampal CA3 of rats.
Acetylcholine (ACh) regulates pain perception in the central nervous system. However, the mechanism of action of ACh on pain-related neurons in the hippocampal CA3 is not clear. The present study aimed to determine the effect of ACh, muscarinic ACh receptors (mAChRs) agonist pilocarpine and mAChRs antagonist atropine on the pain-evoked responses of pain-excited neuron (PEN) and pain-inhibited neuron (PIN) in the hippocampal CA3 of normal rats. The trains of electric impulses applied to the sciatic nerve were used as noxious stimulation. The electric activities of PEN or PIN in the hippocampal CA3 were recorded by using a glass microelectrode. Our results showed that, in the hippocampal CA3, the intra-CA3 microinjection of ACh (2 μg/1 μl) or pilocarpine (2 μg/1 μl) decreased the discharge frequency and prolonged firing latency of PEN, and increased the discharge frequency and shortened firing inhibitory duration (ID) of PIN, i.e. exhibiting the analgesic effect of ACh or pilocarpine. The intra-CA3 administration of atropine (0.5 μg/1 μl) produced an opposite effect. On the basis of the above-mentioned findings, we can deduce that ACh and mAChRs in the hippocampal CA3 are involved in the modulation of nociceptive response by regulating the electric activities of PEN and PIN.
Department of Neurology, Second Affiliated Hospital, Harbin Medical University, 194 Xuefu Road, Nangang District, Harbin, 150081, Heilongjiang, China.
G-Z
GZ
Li
Q-C
QC
Liang
Y-H
YH
Jin
C-X
CX
Yang
G-W
GW
Zhang
H-R
HR
Gao
D
D
Zhang
M-Y
MY
Xu
D000109:Acetylcholine / Q000494:pharmacology* / Q000502:physiology; D000200:Action Potentials / Q000187:drug effects* / Q000502:physiology; D000818:Animals; D056654:CA3 Region, Hippocampal / Q000187:drug effects* / Q000503:physiopathology*; D018679:Cholinergic Agonists / Q000494:pharmacology; D004558:Electric Stimulation / Q000009:adverse effects / Q000379:methods; D005260:Female; D018721:Muscarinic Agonists / Q000494:pharmacology; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology*; D051381:Rats; D017208:Rats, Wistar
D018679:Cholinergic Agonists; D018721:Muscarinic Agonists; D018727:Muscarinic Antagonists; D000109:Acetylcholine
Neurosci Bull. 2007 Nov;23(6):323-8
18064061
Indian J Pharmacol. 2009 Jun;41(3):144-7
20442824
Biochem Biophys Res Commun. 2008 Jul 18;372(1):179-85
18474221
Pharmacol Biochem Behav. 2003 Mar;74(4):977-86
12667913
Neuroscience. 2007 Nov 23;149(4):760-7
17964734
Neuron. 2010 Oct 6;68(1):113-26
20920795
J Neurosci. 2010 Jun 16;30(24):8296-307
20554881
Neuroscience. 1999 Mar;89(1):61-71
10051217
J Biol Chem. 2008 Nov 14;283(46):31884-97
18755690
Neurosci Lett. 2010 Jul 26;479(2):157-60
20510338
J Pharmacol Exp Ther. 2005 May;313(2):765-70
15665136
J Neural Transm (Vienna). 2008;115(1):1-6
17851635
Br J Pharmacol. 2000 Apr;129(8):1633-40
10780968
Int J Neurosci. 1993 Sep;72(1-2):15-29
8225797
Hippocampus. 1998;8(6):566-607
9882017
Exp Neurol. 2001 Nov;172(1):92-9
11681843
Pharmacol Biochem Behav. 2009 May;92(3):480-7
19463263
Brain. 1978 Mar;101(1):83-117
638728
Toxicon. 2006 Aug;48(2):175-82
16857228
Nat Rev Neurosci. 2008 Mar;9(3):182-94
18270514
Behav Neurosci. 1985 Dec;99(6):1031-9
3843537
J Neurophysiol. 2003 Jun;89(6):3018-28
12611982
Nat Rev Neurosci. 2001 Jan;2(1):51-61
11253359
Eur J Pharmacol. 1985 Oct 29;117(1):81-8
3841316
J Mol Neurosci. 2006;30(1-2):161-4
17192666
Nat Rev Neurosci. 2009 Apr;10(4):272-82
19300446
Biochem Biophys Res Commun. 2009 Feb 20;379(4):975-9
19135983
Biochem Biophys Res Commun. 2010 May 7;395(3):407-11
20382122
Pharmacol Biochem Behav. 2008 Dec;91(2):252-60
18778727
Mol Pain. 2009 Sep 22;5:55
19772643